3.4.2.4. summary evidence recommendations drug treatments. summary evidencelelong-term efficacy safety antimuscarinic therapy ndo well documented.1amirabegron shown similar symptom related clinical effects compared antimuscarinics.1bmirabegron improve urodynamic parameters ndo patients.1amaximise outcomes ndo considering combination therapy3 recommendationsstrength ratinguse antimuscarinic therapy first-line medical treatment neurogenic detrusor overactivity.strongdo use mirabegron intention reducing urodynamically proven neurogenic detrusor overactivity.strongprescribe Î±-blockers decrease bladder outlet resistance.strongdo prescribe parasympathomimetics underactive detrusor.strong